• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.82% Nasdaq Up 2.46%

    Trevena, Inc. (TRVN)

    -NasdaqGS
    11.44 Up 2.35(25.85%) Sep 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:9.09
    Open:9.51
    Bid:11.00 x 700
    Ask:11.40 x 900
    1y Target Est:16.06
    Beta:N/A
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:9.21 - 11.47
    52wk Range:3.80 - 11.47
    Volume:11,733,759
    Avg Vol (3m):982,048
    Market Cap:492.63M
    P/E (ttm):N/A
    EPS (ttm):-1.57
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    TRVNUp 25.85%492.63M
    CYTKUp 4.96%279.00M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):156.57
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.33
    Quarterly EPS Est (Sep-15) :-0.36
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trevena, Inc., a clinical stage biopharmaceutical company, discovers, develops, and intends to commercialize therapeutics for G protein coupled receptors. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback